342 related articles for article (PubMed ID: 12365204)
1. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
Ette EI; Onyiah LC
Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
[TBL] [Abstract][Full Text] [Related]
2. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
3. Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. I: A use of bootstrap standard error.
Yafune A; Ishiguro M
Stat Med; 1999 Mar; 18(5):581-99. PubMed ID: 10209813
[TBL] [Abstract][Full Text] [Related]
4. Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. II: A bootstrap modification of standard two-stage (STS) method for phase I trial.
Yafune A; Ishiguro M
Stat Med; 1999 Mar; 18(5):601-12. PubMed ID: 10209814
[TBL] [Abstract][Full Text] [Related]
5. Stability and performance of a population pharmacokinetic model.
Ette EI
J Clin Pharmacol; 1997 Jun; 37(6):486-95. PubMed ID: 9208355
[TBL] [Abstract][Full Text] [Related]
6. Estimation of population pharmacokinetic parameters in the presence of non-compliance.
Mu S; Ludden TM
J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):53-81. PubMed ID: 12800807
[TBL] [Abstract][Full Text] [Related]
7. Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.
Dumont C; Mentré F; Gaynor C; Brendel K; Gesson C; Chenel M
Clin Pharmacokinet; 2013 Jan; 52(1):43-57. PubMed ID: 23212609
[TBL] [Abstract][Full Text] [Related]
8. The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.
Kjellsson MC; Jönsson S; Karlsson MO
AAPS J; 2004 Aug; 6(3):e19. PubMed ID: 15760104
[TBL] [Abstract][Full Text] [Related]
9. Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects models.
Baverel PG; Savic RM; Karlsson MO
J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):63-82. PubMed ID: 21076858
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis.
White DB; Walawander CA; Tung Y; Grasela TH
J Pharmacokinet Biopharm; 1991 Feb; 19(1):87-112. PubMed ID: 2023111
[TBL] [Abstract][Full Text] [Related]
11. The effect of collinearity on parameter estimates in nonlinear mixed effect models.
Bonate PL
Pharm Res; 1999 May; 16(5):709-17. PubMed ID: 10350015
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
[TBL] [Abstract][Full Text] [Related]
13. The influence of sparse data sampling on population pharmacokinetics: a post hoc analysis of a pharmacokinetic study of morphine in healthy volunteers.
Ariano RE; Duke PC; Sitar DS
Clin Ther; 2012 Mar; 34(3):668-76. PubMed ID: 22381713
[TBL] [Abstract][Full Text] [Related]
14. Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel.
Dansirikul C; Choi M; Duffull SB
Comput Biol Med; 2005 Jun; 35(5):389-403. PubMed ID: 15767115
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases.
Hong Y; Shaw PJ; Nath CE; Yadav SP; Stephen KR; Earl JW; McLachlan AJ
Antimicrob Agents Chemother; 2006 Mar; 50(3):935-42. PubMed ID: 16495254
[TBL] [Abstract][Full Text] [Related]
16. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.
Bauer RJ; Guzy S; Ng C
AAPS J; 2007 Mar; 9(1):E60-83. PubMed ID: 17408237
[TBL] [Abstract][Full Text] [Related]
17. On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data.
Sun H; Ette EI; Ludden TM
J Pharmacokinet Biopharm; 1996 Dec; 24(6):637-50. PubMed ID: 9300354
[TBL] [Abstract][Full Text] [Related]
18. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
[TBL] [Abstract][Full Text] [Related]
19. Balanced designs in longitudinal population pharmacokinetic studies.
Ette EI; Sun H; Ludden TM
J Clin Pharmacol; 1998 May; 38(5):417-23. PubMed ID: 9602953
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of flucytosine: comparison and validation of three models using STS, NPEM, and NONMEM.
Vermes A; Math t RA; van der Sijs IH; Dankert J; Guchelaar HJ
Ther Drug Monit; 2000 Dec; 22(6):676-87. PubMed ID: 11128235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
